PGEN übertreffen die 11 der letzten 40Schätzungen.
28%
Nächster Bericht
Datum des nächsten Berichts
17. März 2026
Estimate forQ4 25(Revenue/ EPS)
$8.45M
/
-$0.08
Implizierte Änderung vonQ3 25(Revenue/ EPS)
+189.23%
/
-92.45%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+610.20%
/
+33.33%
Precigen, Inc. Common Stock earnings per share and revenue
On 13. Nov. 2025, PGEN reported earnings of -1.06 USD per share (EPS) for Q3 25, missing the estimate of -0.09 USD, resulting in a -993.91% surprise. Revenue reached 2.92 million, compared to an expected 510.00 tausend, with a 472.94% difference. The market reacted with a +25.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.08 USD, with revenue projected to reach 8.45 million USD, implying an decrease of -92.45% EPS, and increase of 189.23% in Revenue from the last quarter.
FAQ
What were Precigen, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Precigen, Inc. Common Stock reported EPS of -$1.06, missing estimates by -993.91%, and revenue of $2.92M, 472.94% above expectations.
How did the market react to Precigen, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 25.65%, changed from $3.86 before the earnings release to $4.85 the day after.
When is Precigen, Inc. Common Stock expected to report next?
The next earning report is scheduled for 17. März 2026.
What are the forecasts for Precigen, Inc. Common Stock's next earnings report?
Based on 5
analysts, Precigen, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $8.45M for Q4 2025.